| Model Number |
SGC0801 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Thrombosis/Thrombus (4440)
|
| Date of Event |
07/27/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported on (b)(6)2026 that the patient presented with grade 4 functional mitral regurgitation (mr) and a restricted posterior leaflet for a mitraclip procedure.During the procedure, an attempt was made to advance the steerable guide catheter (sgc) across the septum.A thrombus was observed on the transseptal wire within the left atrium.At that time, the sgc dilator was positioned across the septum in close proximity to the thrombus.The dilator was carefully advanced just distal to the thrombus, aspiration was performed using a 50 cc syringe, heparin was administered and the sgc was subsequently withdrawn over the wire.In the interest of patient safety, a new sgc was used to successfully complete the procedure.The patient was reported to be in stable condition.The mr was reduced to grade 1 post procedure.There was no clinically significant delay reported.
|
| |
|
Event or Problem Description
|
|
It was reported on (b)(6) 2026 that the patient presented with grade 4 functional mitral regurgitation (mr) and a restricted posterior leaflet for a mitraclip procedure.During the procedure, an attempt was made to advance the steerable guide catheter (sgc) across the septum.A thrombus was observed on the transseptal wire within the left atrium.At that time, the sgc dilator was positioned across the septum in close proximity to the thrombus.The dilator was carefully advanced just distal to the thrombus, aspiration was performed using a 50 cc syringe, heparin was administered and the sgc was subsequently withdrawn over the wire.In the interest of patient safety, a new sgc was used to successfully complete the procedure.The patient was reported to be in stable condition.The mr was reduced to grade 1 post procedure.There was no clinically significant delay reported.
|
| |
|
Additional Manufacturer Narrative
|
|
The device is not returning for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
| |
|
Additional Manufacturer Narrative
|
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, a cause for the reported thrombosis cannot be determined.The reported medication and unexpected medical intervention are case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|
| |
|
Search Alerts/Recalls
|